CLINICAL_TRIALS
trial_result
· 2018-01-12
Clinical Trial Update: Trial of CPX-351 in Newly Diagnosed Elderly AML Patients [Phase 2]
Summary
Phase 2 trial update of CPX-351 in newly diagnosed elderly patients with acute myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jazz Pharmaceuticals | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-01-12